Related Experiment Videos
Using in silico transcriptomics to search for tumor-associated antigens for immunotherapy
1Glaxo SmithKline Biologicals, 89 rue de l'Institut, 1330, Rixensart, Belgium. carla.vinals@sbbio.be
Vaccine
|March 21, 2001
Summary
This study introduces a novel computational method to identify potential cancer antigens from expressed sequence tag (EST) databases. This approach enhances the discovery of tumor-specific targets for more effective immunotherapy with fewer side effects.
Area of Science:
- Oncology
- Immunology
- Bioinformatics
Background:
- Cancer immunotherapies aim to elicit an immune response against tumor cells using self-antigens.
- Minimizing autoimmunity requires highly tumor-specific antigens.
- In silico screening of genomic databases complements experimental tumor antigen discovery.
Purpose of the Study:
- To develop an efficient computational method for identifying novel tumor-associated genes from expressed sequence tag (EST) databases.
- To improve the selection of candidate antigens for cancer immunotherapy.
Main Methods:
- Utilized a novel screening strategy for large-scale expressed sequence tag (EST) databases.
- Focused on identifying genes expressed in tumor tissues across various cancer types.
- Leveraged publicly available cDNA tissue library data.
Main Results:
- Developed a method for efficient selection of potential tumor-associated genes.
- The candidate gene list was enriched with known tumor-expressed genes.
- Demonstrated the feasibility of in silico discovery of immunotherapy targets.
Conclusions:
- The novel EST screening method efficiently identifies promising tumor-associated antigens.
- This computational approach aids in discovering new targets for cancer immunotherapy.
- The method facilitates the selection of antigens with reduced risk of autoimmunity.